{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:42:37Z","timestamp":1772833357520,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG054025"],"award-info":[{"award-number":["R01AG054025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG060718"],"award-info":[{"award-number":["R01AG060718"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS094557"],"award-info":[{"award-number":["R01NS094557"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RFA1AG055771"],"award-info":[{"award-number":["RFA1AG055771"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17CSA33620007"],"award-info":[{"award-number":["17CSA33620007"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008013","name":"University of Texas Medical Branch at Galveston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010470","name":"Gillson Longenbaugh Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019900","name":"Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jbc.2024.105628","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T02:53:00Z","timestamp":1704855180000},"page":"105628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["C9orf72-associated dipeptide protein repeats form A11-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia"],"prefix":"10.1016","volume":"300","author":[{"given":"Nemil","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicha","family":"Puangmalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urmi","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-7768","authenticated-orcid":false,"given":"Madison","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailee","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.105628_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/brain\/awr354","article-title":"Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p","volume":"135","author":"Hsiung","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2024.105628_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-018-0436-1","article-title":"FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer\u2019s disease","author":"Novak","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jbc.2024.105628_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/156720511795563700","article-title":"FTD and ALS: a tale of two diseases","volume":"8","author":"Ferrari","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jbc.2024.105628_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105130","article-title":"TDP-43 and tau oligomers in Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and frontotemporal dementia","volume":"146","author":"Montalbano","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2024.105628_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17482960802372371","article-title":"The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis","volume":"9","author":"Strong","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jbc.2024.105628_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnins.2020.00042","article-title":"The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"14","author":"Abramzon","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jbc.2024.105628_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A\u00a0hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.105628_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jbc.2024.105628_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of toxicity from ALS\/FTD-Linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.105628_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jbc.2024.105628_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2024.105628_bib12","article-title":"Molecular mechanisms of neurodegeneration related to C9orf72 hexanucleotide repeat expansion","author":"Leko","year":"2019","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.jbc.2024.105628_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/brain\/awr365","article-title":"Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72","volume":"135","author":"Cooper-Knock","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2024.105628_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.conb.2015.10.009","article-title":"An amyloid-like cascade hypothesis for C9orf72 ALS\/FTD","volume":"36","author":"Edbauer","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jbc.2024.105628_bib15","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1074\/jbc.M115.694273","article-title":"The glycine-alanine dipeptide repeat from C9 or f72 hexanucleotide expansions forms toxic amyloids possessing cell-to-cell transmission properties","volume":"291","author":"Chang","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.105628_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-018-1946-4","article-title":"C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in\u00a0vivo to induce a toxic translational arrest that is rescued by eIF1A","volume":"137","author":"Moens","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2024.105628_bib17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.neuron.2014.12.010","article-title":"Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS\/FTD form toxic nuclear aggregates that initiate invitro and invivo neuronal death","volume":"84","author":"Wen","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.105628_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00035","article-title":"The role of dipeptide repeats in C9ORF72-related ALS-FTD","volume":"10","author":"Freibaum","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jbc.2024.105628_bib19","article-title":"How dipeptide repeats cause pathology","author":"Hurtley","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.105628_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3774","article-title":"C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy","volume":"12","author":"Cook","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2024.105628_bib21","article-title":"Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS\/FTD","author":"Odeh","year":"2020","journal-title":"Emerg. Top Life Sci."},{"key":"10.1016\/j.jbc.2024.105628_bib22","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.105628_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","article-title":"P62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND\/ALS","volume":"122","author":"Al-Sarraj","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2024.105628_bib24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/brain\/awr361","article-title":"Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features","volume":"135","author":"Mahoney","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2024.105628_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1440-1789.2011.01286.x","article-title":"An MND\/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline","volume":"32","author":"Troakes","year":"2012","journal-title":"Neuropathology"},{"key":"10.1016\/j.jbc.2024.105628_bib26","article-title":"Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS\/FTD","author":"Odeh","year":"2020","journal-title":"Emerg. Top Life Sci."},{"key":"10.1016\/j.jbc.2024.105628_bib27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer\u2019s disease facts and figures","volume":"18","year":"2022","journal-title":"Alzheimer\u2019s Demen."},{"key":"10.1016\/j.jbc.2024.105628_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2017.06.001","article-title":"Multiple mechanisms of neurodegeneration and progression","author":"Herrero","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jbc.2024.105628_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jbc.2024.105628_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40478-020-01012-6","article-title":"P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer\u2019s disease","volume":"8","author":"Farmer","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2024.105628_bib31","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s12035-020-01913-6","article-title":"Polymorphic \u03b1-synuclein strains modified by dopamine and docosahexaenoic acid interact differentially with tau protein","volume":"57","author":"Sengupta","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jbc.2024.105628_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165084","article-title":"Distinct C9orf72-associated dipeptide repeat structures correlate with neuronal toxicity","volume":"11","author":"Flores","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.105628_bib33","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1038\/s41467-021-23691-y","article-title":"Proline\/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis","volume":"12","author":"Babu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.105628_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-013-1149-y","article-title":"Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons","volume":"126","author":"Almeida","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2024.105628_bib35","doi-asserted-by":"crossref","first-page":"637548","DOI":"10.3389\/fncel.2021.637548","article-title":"Emerging perspectives on dipeptide repeat proteins in C9ORF72 ALS\/FTD","volume":"15","author":"Schmitz","year":"2021","journal-title":"Front. Cell Neurosci"},{"key":"10.1016\/j.jbc.2024.105628_bib36","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R118.003237","article-title":"Repeat-associated non-ATG (RAN) translation","volume":"293","author":"Cleary","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.105628_bib37","first-page":"5069","article-title":"Modelling C9orf72 dipeptide repeat proteins of a physiologically relevant size","volume":"25","author":"Callister","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2024.105628_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"Kayed","year":"2007","journal-title":"Mol. Neurodegener"},{"key":"10.1016\/j.jbc.2024.105628_bib39","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.105628_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.celrep.2016.09.032","article-title":"Cell-to-Cell transmission of dipeptide repeat proteins linked to C9orf72-ALS\/FTD","volume":"17","author":"Westergard","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2024.105628_bib41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molcel.2019.03.019","article-title":"C9orf72 poly(PR) dipeptide repeats disturb biomolecular phase separation and disrupt nucleolar function","volume":"74","author":"White","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.105628_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053785","article-title":"Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.105628_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jbc.2024.105628_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/0-387-25919-8_3","article-title":"Relative importance of hydrophobicity, net charge, and secondary structure propensities in protein aggregation","volume":"4","author":"Chiti","year":"2006","journal-title":"Protein Misfolding, Aggregat. Conformational Diseases"},{"key":"10.1016\/j.jbc.2024.105628_bib45","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1021\/bi1016233","article-title":"Preparation and characterization of neurotoxic tau oligomers","volume":"49","author":"Lasagna-Reeves","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.105628_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2024.105628_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.105628_bib48","article-title":"Cryo-EM structures of tau filaments from SH-SY5Y cells seeded with brain extracts from cases of Alzheimer\u2019s disease and corticobasal degeneration","author":"Tarutani","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2024.105628_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4939-2978-8_20","article-title":"Preparation of amyloid fibrils seeded from brain and meninges","volume":"1345","author":"Scherpelz","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbc.2024.105628_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76494","article-title":"Assembly of recombinant tau into filaments identical to those of Alzheimer\u2019s disease and chronic traumatic encephalopathy","volume":"11","author":"L\u00f6vestam","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2024.105628_bib51","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.105628_bib52","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol. Psych."},{"key":"10.1016\/j.jbc.2024.105628_bib53","doi-asserted-by":"crossref","first-page":"e26991","DOI":"10.7554\/eLife.26991","article-title":"LTP and memory impairment caused by extracellular A\u03b2 and Tau oligomers is APP-dependent","volume":"6","author":"Puzzo","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2024.105628_bib54","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/acschembio.9b00324","article-title":"The toxicity of misfolded protein oligomers is independent of their secondary structure","volume":"14","author":"Vivoli Vega","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.105628_bib55","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.105628_bib56","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/cb500505m","article-title":"Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity","volume":"9","author":"Mannini","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.105628_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101766","article-title":"Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer\u2019s disease","volume":"298","author":"Puangmalai","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.105628_bib58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41419-020-2503-3","article-title":"Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer\u2019s disease, progressive supranuclear palsy and dementia with Lewy bodies","volume":"11","author":"Puangmalai","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2024.105628_bib59","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/pro.3499","article-title":"Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior","volume":"27","author":"Ghag","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2024.105628_bib63","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/prot.23188","article-title":"Prediction of protein secondary structure from circular dichroism using theoretically derived spectra","volume":"80","author":"Louis-Jeune","year":"2012","journal-title":"Proteins"},{"key":"10.1016\/j.jbc.2024.105628_bib60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fmolb.2022.863141","article-title":"Disordered\u2013ordered protein binary classification by circular dichroism spectroscopy","volume":"9","author":"Micsonai","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jbc.2024.105628_bib61","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/brain\/awt375","article-title":"High molecular mass assemblies of amyloid-\u03b2 oligomers bind prion protein in patients with Alzheimer\u2019s disease","volume":"137","author":"Dohler","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jbc.2024.105628_bib62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fneur.2013.00093","article-title":"Formation and propagation of tau oligomeric seeds","volume":"4","author":"Gerson","year":"2013","journal-title":"Front. Neurol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:45:18Z","timestamp":1762188318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0021925824000048"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.105628","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C9orf72-associated dipeptide protein repeats form A11-positive oligomers in amyotrophic lateral sclerosis and frontotemporal dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.105628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"105628"}}